首页> 外文期刊>Journal of Cardiothoracic Surgery >Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review
【24h】

Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review

机译:经股动脉与经心尖主动脉瓣置换术治疗主动脉瓣狭窄之间30天临床并发症的比较:一项荟萃分析

获取原文
           

摘要

Background Since 2002, transapical aortic valve replacement has been developed as a clinical pathway for transcatheter aortic valve implantation (TAVI). However the appropriate role of TA in the AS population versus TF remains unclear. We performed a meta-analysis to assess if TF has any benefit in reduction of 30-day clinical complications in AS. Methods We conducted a comprehensive search on pub-med and web of knowledge from 2002 through September 2012 using following terms: aortic stenosis, aortic valve replacement, transcatheter aortic valve implantation, TAVI, trans-artery, transfemoral, trans-apical. Studies in the original research or review articles were also considered. Included studies must meet the preconditioned criterias. Two investigators independently browsed the studies by title and abstract, finally making decision according to full-text. Disagreements were discussed in group. Results A total of 20 studies met inclusion criteria’s and were included in the analysis (including 4267 patients in TF group, 2242 in TA group). No random clinical trial, one was a retrospective study, others were prospective trials. Our meta-analysis found that TF had the low incidence of 30-day mortality compared with TA procedure (7.5% versus 11.3%). The incidence of stroke at?≤?30 days was relatively low (3.8% in TF versus 4.0% in TA). Although the incidence of post-operative heart block was high (8.5% versus 7.5%), but no differences were indicated [1.06,95% CI(0.85,1.33)]. Conclusions The result of our meta-analysis suggested that TF may have a low risk for 30-day mortality against TA procedure. No difference was found in the incidence of post-operative stroke and heart block.
机译:背景技术自2002年以来,经导管主动脉瓣置换术已被开发为经导管主动脉瓣植入术(TAVI)的临床途径。然而,尚不清楚TA在AS人群与TF中的适当作用。我们进行了荟萃分析,以评估TF是否可以减少AS的30天临床并发症。方法从2002年至2012年9月,我们使用以下术语对pub-med和知识网络进行了全面搜索:主动脉瓣狭窄,主动脉瓣置换,经导管主动脉瓣植入,TAVI,经动脉,经股动脉,经心尖。还考虑了原始研究或评论文章中的研究。纳入的研究必须符合前提条件。两名研究人员按标题和摘要独立浏览了研究,最后根据全文做出决定。小组讨论了分歧。结果共有20项符合纳入标准的研究被纳入分析(TF组4267例,TA组2242例)。没有随机临床试验,一项是回顾性研究,其他是前瞻性试验。我们的荟萃分析发现,与TA手术相比,TF的30天死亡率较低(7.5%比11.3%)。在≤30天的中风发生率相对较低(TF中为3.8%,TA中为4.0%)。尽管术后心脏传导阻滞的发生率较高(8.5%对7.5%),但未显示差异[1.06,95%CI(0.85,1.33)]。结论我们的荟萃分析结果表明,TF对TA手术30天死亡率的风险可能较低。术后中风和心脏传导阻滞的发生率没有差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号